Ken Griffin acquired 3.91 Million Terns Pharmaceuticals shares worth $16.9 Million. That's 0.02% of their equity portfolio (937th largest holding). The investor owns 4.47% of the outstanding Terns Pharmaceuticals stock. The first Terns Pharmaceuticals trade was made in Q1 2021. Since then Ken Griffin bought shares six more times and sold shares on eight occasions. The investor's estimated purchase price is $26.9 Million, resulting in a loss of 37%.